Warner-Lambert clinafloxacin
Executive Summary
NDA for injectable quinolone was withdrawn Nov. 19, firm discloses in 10-K filing. Warner had been seeking an indication for use in life-threatening infections. An IND "will be maintained to allow for use of the drug in situations where no alternative therapy is possible"